A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Genmab A/S stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,786,428 shares of GMAB stock, worth $36.6 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,786,428
Previous 1,462,459 22.15%
Holding current value
$36.6 Million
Previous $36.8 Million 18.51%
% of portfolio
0.07%
Previous 0.06%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$23.84 - $28.48 $7.72 Million - $9.23 Million
323,969 Added 22.15%
1,786,428 $43.6 Million
Q2 2024

Aug 09, 2024

BUY
$25.13 - $30.27 $2.61 Million - $3.14 Million
103,859 Added 7.64%
1,462,459 $36.8 Million
Q1 2024

May 13, 2024

SELL
$26.43 - $32.77 $3.6 Million - $4.46 Million
-136,200 Reduced 9.11%
1,358,600 $40.6 Million
Q4 2023

Feb 13, 2024

BUY
$27.94 - $35.44 $8.96 Million - $11.4 Million
320,800 Added 27.33%
1,494,800 $47.6 Million
Q3 2023

Nov 14, 2023

BUY
$35.27 - $42.24 $11.8 Million - $14.1 Million
334,900 Added 39.91%
1,174,000 $41.4 Million
Q2 2023

Aug 11, 2023

SELL
$37.4 - $42.94 $7.87 Million - $9.04 Million
-210,500 Reduced 20.06%
839,100 $31.9 Million
Q1 2023

May 12, 2023

SELL
$34.88 - $43.22 $4.92 Million - $6.1 Million
-141,100 Reduced 11.85%
1,049,600 $39.6 Million
Q4 2022

Feb 13, 2023

BUY
$33.8 - $47.06 $9.27 Million - $12.9 Million
274,300 Added 29.93%
1,190,700 $50.5 Million
Q3 2022

Nov 14, 2022

SELL
$31.52 - $373.61 $2.01 Million - $23.8 Million
-63,800 Reduced 6.51%
916,400 $29.4 Million
Q2 2022

Aug 12, 2022

SELL
$26.83 - $38.57 $2.91 Million - $4.18 Million
-108,300 Reduced 9.95%
980,200 $31.8 Million
Q1 2022

May 13, 2022

BUY
$30.95 - $39.68 $436,395 - $559,488
14,100 Added 1.31%
1,088,500 $39.4 Million
Q4 2021

Feb 11, 2022

BUY
$35.87 - $47.12 $6.3 Million - $8.27 Million
175,600 Added 19.54%
1,074,400 $42.5 Million
Q3 2021

Nov 12, 2021

BUY
$41.55 - $48.72 $577,545 - $677,208
13,900 Added 1.57%
898,800 $39.3 Million
Q2 2021

Aug 13, 2021

SELL
$32.88 - $44.57 $3.53 Million - $4.79 Million
-107,400 Reduced 10.82%
884,900 $36.1 Million
Q1 2021

May 13, 2021

SELL
$30.92 - $44.4 $9.86 Million - $14.2 Million
-318,900 Reduced 24.32%
992,300 $32.6 Million
Q4 2020

Feb 10, 2021

SELL
$33.66 - $40.76 $11.8 Million - $14.3 Million
-352,000 Reduced 21.16%
1,311,200 $53.3 Million
Q3 2020

Nov 13, 2020

BUY
$33.07 - $38.68 $18.5 Million - $21.7 Million
560,103 Added 50.78%
1,663,200 $60.9 Million
Q2 2020

Aug 13, 2020

BUY
$20.05 - $33.89 $19.1 Million - $32.4 Million
954,697 Added 643.33%
1,103,097 $37.4 Million
Q1 2020

May 14, 2020

BUY
$17.15 - $25.22 $2.55 Million - $3.74 Million
148,400 New
148,400 $3.15 Million

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $13.5B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.